Go Ad-Free
My Alerts
VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
MARKETS

Panacea Biotec Ltd.

BSE: 531349 | NSE: PANACEABIO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE922B01023 | SECTOR: Pharmaceuticals & Drugs

| BSE 354.80 -20.25 (-5.40%) | |

BSE Live

Feb 11, 16:01
354.80 -20.25 (-5.40%)
Volume
AVERAGE VOLUME
5-Day
5,067
10-Day
5,215
30-Day
85,881
6,365

  • Prev. Close

    375.05

  • Open Price

    378.70

  • Bid Price (Qty.)

    354.80 (2)

  • Offer Price (Qty.)

    354.80 (689)

NSE Live

Feb 11, 15:58
354.60 -19.85 (-5.30%)
Volume
AVERAGE VOLUME
5-Day
111,389
10-Day
116,333
30-Day
876,852
203,426

  • Prev. Close

    374.45

  • Open Price

    376.55

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    354.60 (100)

Financials

Cash Flow of Panacea Biotec (in Rs. Cr.) Mar 10 Mar 09 Mar 08 Mar 07 Mar 06  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 118.08 -92.37 190.47 209.10 100.21  
Net CashFlow From Operating Activities 75.74 4.99 108.68 152.50 158.45  
Net Cash Used In Investing Activities -121.68 -126.19 -423.41 173.03 -527.49  
Net Cash Used From Financing Activities 30.52 157.13 213.82 -236.19 381.82  
Foreign Exchange Gains / Losses 0.00 0.00 -0.08 -3.13 -5.29  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -15.42 35.93 -100.83 92.46 18.07  
Cash And Cash Equivalents Begin of Year 52.43 16.08 116.92 24.45 6.38  
Cash And Cash Equivalents End Of Year 37.02 52.01 16.08 116.92 24.45  
Source : Dion Global Solutions Limited

Results of Panacea Biotec

  • 01.01.1970

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Parallel Income Plan 2026